Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD

Published:2013-12 Issue:12 Volume:107 Page:1904-1911
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Tashkin Donald P.,Li Ning,Halpin David,Kleerup Eric,Decramer Marc,Celli Bartolome,Elashoff Robert

Funder

NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference24 articles.

1. Comparison of the variability of the annual rates of change in FEV1 determined from serial measurements of the pre- versus post-bronchodilator FEV1 over 5 years in mild to moderate COPD: results of the Lung Health Study;Tashkin;Respir Res,2012

2. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study;Anthonisen;JAMA,1994

3. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the lung health study;Scanlon;Am J Respir Crit Care Med,2000

4. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking;Pauwels;N Engl J Med,1999

5. Randomised, double-blind, placebo-controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial;Burge;BMJ,2000

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Value of preoperative evaluation of FEV1 in patients with destroyed lung undergoing pneumonectomy - a 20-year real-world study;BMC Pulmonary Medicine;2024-01-17

2. Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design;ERJ Open Research;2022-11-17

3. Is It Time to Abandon the Postbronchodilator Requirement in Defining Chronic Obstructive Pulmonary Disease?;American Journal of Respiratory and Critical Care Medicine;2022-09-01

4. Risk Factors of Rapid FEV<sub>1</sub> Decline in a Real-World Chronic Obstructive Pulmonary Disease Cohort;Respiration;2022

5.

Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease

;International Journal of Chronic Obstructive Pulmonary Disease;2020-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3